chrisvoncsefalvay/vaers-outcomes huggingface dataset:
been fatigued for over a week; with some Eustachian Tube Disfunction; fluid on the ear; Some associated dizziness; muffled hearing; about 24 hours post injection, I did run a slight fever; about 24 hours post injection / had some chills; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 50-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fatigue, eustachian tube dysfunction, fluid in middle ear, dizziness, muffled hearing in both ears, fever and chills. On an unknown date, the outcome of the fatigue, eustachian tube dysfunction, fluid in middle ear, dizziness and muffled hearing in both ears were not recovered/not resolved and the outcome of the fever and chills were unknown.   It was unknown if the reporter considered the fatigue, eustachian tube dysfunction, fluid in middle ear, dizziness, muffled hearing in both ears, fever and chills to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient himself/ herself. The patient reported that she had received Shingrix vaccine. About 24 hours post injection, she had a slight fever, and had some chills. She had been fatigued for over a week, with some Eustachian tube disfunction and fluid on the ear. She also experienced some associated dizziness and muffled hearing.  She knew that these were not listed among the side effects, and wanted to check. The reporter wanted to know how long do the side effects from the first vaccination typically last.
Mother stated on 7/22/19 at night client had a fever of 101 degrees. And that client had a fever at noon 7/24/19. And the client on 7/24/19 at night had difficulty sleeping due to congestion and wheezing and coughing
Fever; Horrible chills; Bone pain; Difficulty breathing / Shortness of breath; Fogginess; Difficulty focusing; Absolute exhaustion; swelling; Sore throat; Difficulty eating; Voice keeps going hoarse; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Horrible chills), BONE PAIN (Bone pain), DYSPNOEA (Difficulty breathing / Shortness of breath) and FEELING ABNORMAL (Fogginess) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 041C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MIRTAZAPINE for Insomnia, ATENOLOL, AMLODIPINE and LEVOTHYROXINE for an unknown indication.   On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), CHILLS (Horrible chills), BONE PAIN (Bone pain), DYSPNOEA (Difficulty breathing / Shortness of breath), FEELING ABNORMAL (Fogginess), DISTURBANCE IN ATTENTION (Difficulty focusing), FATIGUE (Absolute exhaustion), SWELLING (swelling), OROPHARYNGEAL PAIN (Sore throat), EATING DISORDER (Difficulty eating) and DYSPHONIA (Voice keeps going hoarse). At the time of the report, PYREXIA (Fever), CHILLS (Horrible chills), BONE PAIN (Bone pain), DYSPNOEA (Difficulty breathing / Shortness of breath), FEELING ABNORMAL (Fogginess), DISTURBANCE IN ATTENTION (Difficulty focusing), FATIGUE (Absolute exhaustion), SWELLING (swelling), OROPHARYNGEAL PAIN (Sore throat), EATING DISORDER (Difficulty eating) and DYSPHONIA (Voice keeps going hoarse) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 with the events was considered as not applicable. No treatment medication reported by reporter.   This case was linked to MOD-2021-239351 (Patient Link).
Pt received first dose of pfizer vaccine and began to feel dizzy shortly thereafter. Denies LOC. No SOB noted. Pt given water prior to arrival to med obs #1. Pt son at bedside. Pt reports he had breakfast PTA. Pt son states, "My dad got nervous and a little scared because he was worried about the shot." VS at 1155: BP 142/87, HR 77, RR 17, O2 sat 96% on RA. VS at 1212: BP 126/85, HR 71, RR 17, O2 sat 95% on RA. VSS at time of d/c to home. No s/s of distress noted at time of discharge to home. Pt escorted to exit.
Fatigue, pounding headache, fever 105 degrees F, bodyache. To Urgent Care 3/31/10, pain med was given. Not better, to ER 4/1/10-CT head, spinal tab, blood work: normal, discharged home with pain med. 4/2/10 little better
I developed a big red lump on my arm 6 weeks after vaccination.  We weren't sure it was related to the intradermal flu shot but it was located near where the original vaccination was placed.  Biopsy turned out to be 'granuloma annulare'.
Received the first and second doses at Pharmacy.  Second vaccine shot was on Friday, May 14, 2021, in the left arm.  On Saturday, May 15, 2021, I wasn't feeling well.  Then later in the evening I developed a bulge under the left arm.  The lympth node increased in size; my left arm would ache, especially if I would stretch to reach for something.  I have been applying cold packs.  This situation has now continued for two weeks.
Shortness of breath (decreased peak flow and fev for 10 days as of time of report), brain fog, fatigue, enlarged lymp nodes still exist as of time of report.
Information has been received from a health professional concerning a 30 year old female with no pertinent medical history who on 07-MAY-2007 was vaccinated intramuscularly with Gardasil (lot #657736/0389U).  Concomitant therapy included ethinyl estradiol (+) etonogestrel (NUVARING).  On 07-MAY-2007, five hours after receiving the first dose of the vaccination, the patient experienced a feeling like her throat was swollen and nausea.  On 08-MAY-2007 the patient experienced swelling of the face, swelling of both hands, tiny bumps on both hands and low grade fever of 100.9F.  The patient was examined by a physician and prescribed oral diphenhydramine hydrochloride (Benadryl).  At the time of the report the patient had not recovered.  There were no laboratory or diagnostic tests performed.  Additional information has been requested. 10/08/07 This is in follow-up to report(s) previously submitted on 6/14/2007. Information has been received from a health professional concerning a 30 year old female, with no pertinent medical history, who on 07-MAY-2007 at 2:00 pm was vaccinated in the right deltoid with a first dose of GARDASIL (lot # 657736/0389U). Concomitant therapy included NUVARING. On 07-MAY-2007 at 7:00 pm the patient experienced a feeling like her throat was swollen, nausea and swelling of both hands with tiny bumps. On 08-MAY-2007 the patient experienced swelling of the face and low grade fever of 100.9F. The patient was examined by a physician and prescribed oral BENADRYL. There were no laboratory or diagnostic tests performed. On 09-MAY-2007, the patient recovered from a feeling like her throat was swollen, nausea, swelling of the face, swelling of both hands, tiny bumps on both hands and low grade fever of 100.9F. Additional information is not expected.
Cellulitis in Left Deltoid where vaccine administered.  Admitted to hospital on 10/06/2012 and received Vancomycin IV.
began to have burning sensation on the left side of  upper body; Shingles; Postherpetic neuralgia; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 26Mar2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included desvenlafaxine succinate monohydrate (PRISTIQ) from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN4199) via an unspecified route of administration in the left arm on 04Mar2021 at 09:00 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. On 27Mar2021 at 03:30, with 24 hours the patient experienced burning sensation on the left side of upper body; the same side both vaccines were administered. On an unknown date in Mar2021 the patient experienced within 3 days developed what appeared to be shingles, went to the doctor and was diagnosed with shingles. After the rash went away on an unknown date in 2021 the patient experienced; was diagnosed with post herpetic neuralgia. Patient stated that she believed the shingles was a result of the vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with medication (Names unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events burning sensation on the left side of upper body, shingles, after the rash went away was diagnosed with post herpetic neuralgia was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
fogginess; fatigue; This is a spontaneous report received from contactable consumer (patient) via a Pfizer-sponsored program . A male patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date were not reported) via an unspecified route of administration, on an unspecified date at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date (3 days after the first dose), the patient experienced fogginess and fatigue. Patient enquired whether he could use Flonase. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Arm is swollen with red streak from injection site to elbow and it's painful. Patient went to urgent care.
I felt dizzy and sick, very weak that first day. I was fine until 7 days later. I started breaking out in a rash around my sacrum. I am still experiencing the rash growing all over my body. It is extremely itchy.
Pt did not have an adverse event.  However, pt presented for the newest Covid Booster.  After giving pt Pfizer bivalent she presented cards that showed she already received Covid bivalent on 09/20/22 from her Dr. office.  So pt accidently received a 2nd Pfizer bivalent booster dose.
1 month after immunization child began to limp and cried a lot. Mother took to PCP who  referred to rheumatologist. Disease progressed to all joints Dx- Juvenile Rheumatoid Arthritis Poly Articular type (many joints)
pt recvd vax;3/4" area redness immed p/ vax;responded to ice tx;mom instructed to call if area worsens;
Guillain Barre syndrome/AIDP event. Paresthesia and nerve pain developed in bilateral legs 4 hours after shot and progressed slowly for 4 days in intensity and area involved. Symptoms progressed distally to superior. On the 5th day symptoms progressed rapidly and involved bilateral legs up to the groin, left arm up to lateral shoulder, and right hand. I went to the hospital and was admitted to start IVIG treatment for Guillain Barre Syndrome/AIDP.
A week post vaccine, around 11/05/2021, at first, I noticed a little bit of peeling on the bottom of both my feet. I thought it was athlete's foot and I applied athlete foot spray. It started little round, and began to scale, white, it began breaking open and starts to spread. And it continues to reoccur and merge into the old area. Then I used some fungal cream, and that was not helping. It was itching so I applied Lotrisone. I tried to use that, and it was not helping. I used both of those for 2 or 3 weeks and then the cream for a week, and the Lotrisone. I added a bacterial cream, topical antibiotic cream. and that started helping, and as soon as I stopped using it came back. I was using it 2 or 3 times a day. When I stopped using it, it started spreading again. my right foot is worse than the left. The rash is going up to the ankle, in the arch area. It is better with the antibiotic after 2 weeks, but once I stopped using it began spreading again. I have not recovered from the AE.
Red and hot rash at injection site. Muscle ache, Mild headache, Extreme fatigue, and Breakthrough bleeding.
This is a spontaneous report from a contactable consumer or other non hcp. A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: FA6780) via an unspecified route of administration, administered in Arm Left on 28Jul2021 12:00 (at the age of 69-year-old) as dose 2, single for COVID-19 immunization at Pharmacy. The patient medical history and concomitant medications were not reported. Relevant past drug history was none. Patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EW0185), via an unspecified route of administration, administered in Arm Left on 07Jul2021 at 11:00 am (at the age of 69-year-old) as dose 1, single for COVID-19 immunization. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Jul2021 at 22:00, the patient experienced large red swollen rash on arm where it was administered and on 29Jul2021, patient had covid arm, large hard swollen lump-ned, that hurt to touch, skin has a small amount of discoloration left, have a mild burning sensation where the lump was. Seriousness criteria was reported as not Serious. Patient had not received any treatment. It was reported that, Swelling was almost all gone. Patient still had a mild burning sensation where the lump was, but it seems to be getting better. Patient did not have any other side effects. Clinical outcome of the events large red swollen rash on arm where it was administered was not recovered and recovering for rest events.  Follow-up attempts are completed. No further information is expected.
contracted COVID; contracted COVID; This is a spontaneous report received from a Pfizer sponsored program from a contactable Other-HCP (patient). A 34-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EJ1685), via an unspecified route of administration in the left deltoid on 18Dec2020 at SINGLE DOSE for covid-19 immunisation. Medical history was reported as none.  There were no concomitant medications. He got the first dose of the COVID Vaccine on 18Dec2020. He then contracted COVID on 03Jan2021. The patient clarified that he started with symptoms on 03Jan2021. He tested negative for COVID on 04Jan2021 and then tested positive on 05Jan2021. He was supposed to get the second dose on 08Jan2021. He wanted to know how to proceed with receiving the second dose. Inquiring how long it will be effective. The outcome of the event was unknown.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. Further information like confirmative virus genome /nucleic acid detection is needed for meaningful medical assessment.
Fever begain 6/6/21 for 2 weeks along with 15+ lb. weight loss.  Went to Hospital and was admitted 6/21 with Tachacardia, high blood pressure and fever.  Diagnised with Hyperthyroidism on 6/23 and relleased on 6/24 with bllod pressure and thyroid medicicine.   Follinging up with Dr. and trying to get into Endocronologist. Item # 21: 3 days in hospital
Initial report received from a nurse on 17 Mar 2010: This patient was vaccinated with FLUVIRIN, intramuscular, ml, on an unspecified date. The patient was vaccinated with expired vaccine (date unspecified). The reporter stated she didn't knew of any adverse events. The outcome of the event, seriousness criteria and causality were not reported.
On 03/10/2023, I spoke with a doctor and informed them I had tested positive for COVID-19. I was experiencing pain, sweats, and coughing. I did admit to being sick in the past week. I normally smoke one to one and a half packs of cigarettes in a day. One day last week, I got up to three packs. The doctor advised that I may have pneumonia and prescribed a Z-PAK and prednisone. He stated that my issues were due to tobacco abuse. He claimed that he gave me counseling in regard to tobacco abuse but did not. On 03/13/2023, I was still having symptoms and needed to be relieved from work. I needed to have a letter from my doctor to excuse me. He stated that it had been five days and I was cleared for work.
knot at site of injection; This case was reported by a pharmacist via call center representative and described the occurrence of injection site lump in a 66-year-old female patient who received Herpes zoster (Shingrix) (batch number 4RR52, expiry date 7th December 2021) for prophylaxis.   On 20th August 2019, the patient received the 1st dose of Shingrix (intramuscular). On 20th August 2019, less than a day after receiving Shingrix, the patient experienced injection site lump. On an unknown date, the outcome of the injection site lump was unknown.   It was unknown if the reporter considered the injection site lump to be related to Shingrix.  Additional information received were as follows: The caller was a pharmacist reporting that the patient experienced a knot at the site of the injection about the size of a dime and had not resolved.
20 min after the injection my lips started tingling and getting numb. Under my nose was numb, felt like I had novacaine. 1 hour and 30 minutes later my throat swelled. I had a hard time getting water down my throat. I took two benadryl pills at 11:10 am. Throat swelling went away within 10 minutes of taking benadryl and I was able to eat without any issues. My lips are still tingling, it's been 7 hours since the injection.
This spontaneous report as received from a registered nurse refers to a adult female patient of unknown age. On an unknown date the patient was vaccinated with 3-dose series of RECOMBIVAX HB for required. The patient was "tested in the past couple of weeks" for hepatitis B surface antibodies (in approximately 2013). The "test" came back "negative". There was no treatment given for the event. The outcome of hepatitis b surface antibodies negative was unknown. Additional information has been requested.
Information has been received from a nurse concerning four patients who on unspecified dates was vaccinated with a dose of VARIVAX (Merck) (LOT# not reported). On unreported dates, after vaccination, the patients experienced local injection site reactions. No further information was available at time of this report. Follow-up information has been received from a nurse concerning a 4 year old male who in the week or so of 24-JUL-2009 was vaccinated with a dose of VARIVAX (Merck). "During the week or so of 24-JUL-2009", the patient experienced site reactions. He had recovered at the time of this report. Follow up information has been received from a registered nurse concerning a 4 year old male patient with no illness at time of vaccination who on 30-JUL-2009 was vaccinated SQ with the second dose of VARIVAX (Merck) (lot# 664355/0655Y). Secondary suspect vaccination on the same day included the second SQ dose of MMR II (lot# 663798/0357Y). Concomitant vaccinations on the same day included a first dose of DTaP (IM, lot# C3141AA) and a fourth dose of Poliovirus vaccine inactivated (unspecified) (IM lot# B0475). On 31-JUL-2009, at 12:59 PM, the patient experienced local reaction, redness and induration from deltoid to elbow. Medical attention was sought, the patient had an office visit. The patient was treatment with MOTRIN and ice. On an unspecified date, the adverse events resolved without further incident. This is one of several reports from the same source. Additional information is not expected.
Memory and cognitive deficit May to present - Hair loss, nose bleeds, fatigue, lethargy, dry eyes, positive ANA test for an autoimmune Dx for either lupus, MS, arthritis and Sjorgrens Dr - neuro hospital. Continues treatment.
7 days after receiving vaccine, patient ran high fever, resulting in seizures. Results of seizures caused his brain to swell, causing permanent disability. Doctors said if he survived at all, he would be a total vegetable. Through prayer, and a lot of therapy, he is doing well and is close to being normal again. Doctors say he probably never be completely normal, but they are happy with progress. He is on numerous seizure medications to prevent a recurrence. ER record & Discharge summary on 05/06/04 states: febrile seizure, acute upper respiratory infection, pharyngitis, otitis media, gastritis, viral exanthema. Medical record on 05/06/04 states: afebrile seizures.  Nurse follow up on 06/03/04 states: "ADD: status epilepticus, papilledema, encephalitis, cerebral infarcts, cortical visual impairment (convuls grand mal, papilledema, encephalitis, infarct cerebr, vision abnorm)."  Per annual follow up report: 05/01/05 to date patient continues on seizure meds and continues therapy OT, pt speech, early Ed w/ develoopmental delays also receives neurodevelopmental therapy, has significant speech delays, pt is very small for age, has not grown significantly since original injury. Age 3yrs 8 months weight 25 lbs, height 36 inches.
At a well visit on 12/21/2011 at approx. 5p.m. patient who complained only of a minimal sore throat received her DPT in her right deltoid. Fine last pm - no site rxn - no fever - awoke felt nauseous x2, lightheaded x2, in shower she had a syncopal event.
The patient developed redness and warmth at site of injections.  No pain, no pruritis.  Patient received Keflex PO x 10 days.
Mother of pt states she developed a hive on her face approx 48 hrs after receiving vaccines.  Then 12 hrs later developed hive-like rash on arms, buttocks + legs.  Seen at office 72 hrs after receiving vaccine.  Temp 98 degrees ax Dx: urticaria prob 2 hours from injection inflammation but was delayed 24.48 hrs so not consistent with allergy.
Patient stated she felt light headed, tingling in the left arm and numbness 5 minutes after vaccination.  She drank some water and was monitored for 15 minutes.  After 15 minitues she stated she felt better and ok.  She also  stated she had  same experience during her 2nd dose at the Clinic.
fever (100/F), severe arthralgia, myalgia, malaise, mild stomach distress, headache. fever lasted ~ 16 hours. other symptoms ~ 20 hours. malaise 2 days. no one in house sick (including 2 1/2 year old), no coworkers sick.
Information has been received from a registered nurse concerning a 6 year old male patient who was vaccinated with a dose of varicella virus vaccine live.  On 06/10/2004, the patient developed a breakthrough case of chickenpox.  The patient had over 50 lesions on his trunk and bottom.  There was no fever.  Unspecified medical attention was sought, but treatment was not required.  A product quality complaint was not involved.  Additional information has been requested.
Persistent left shoulder pain after flu shot 9/21/15. The pain has never stopped. I have difficulty moving my left arm. I have received treatment from 3 MDs, including medications, sling, injection, PT and weight restrictions etc.